TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY Trademark

Trademark Overview

On Thursday, October 14, 2010, a trademark application was filed for TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY with the United States Patent and Trademark Office. The USPTO has given the TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY trademark a serial number of 79089155. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Wednesday, October 14, 2020. This trademark is owned by IPSEN PHARMA S.A.S.. The TULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting medical, pharmaceutical and scientific study programs, conducting clinical studies and analyses, scientific, medical and pharmaceutical research
tulipia trial using bim23a760 dose levels in patients in acromegaly

General Information

Serial Number79089155
Word MarkTULIPIA TRIAL USING BIM23A760 DOSE LEVELS IN PATIENTS IN ACROMEGALY
Filing DateThursday, October 14, 2010
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateWednesday, October 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConducting medical, pharmaceutical and scientific study programs, conducting clinical studies and analyses, scientific, medical and pharmaceutical research
Pseudo MarkTULIPIA TRIAL USING BIM 23 A 760 DOSE LEVELS IN PATIENTS IN ACROMEGALY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, October 14, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Sunday, November 14, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, November 13, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, November 24, 2012NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, August 31, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 10, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 10, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 25, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 25, 2012NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 10, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, August 10, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 2, 2011UNDELIVERABLE MAIL - NO ACTION TAKEN
Saturday, January 29, 2011REFUSAL PROCESSED BY IB
Monday, January 10, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 7, 2011REFUSAL PROCESSED BY MPU
Friday, January 7, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 6, 2011NON-FINAL ACTION WRITTEN
Wednesday, January 5, 2011ASSIGNED TO EXAMINER
Tuesday, November 30, 2010APPLICATION FILING RECEIPT MAILED
Friday, November 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 25, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

patients acromegaly levels dose trial using tulipia conducting pharmaceutical scientific medical analyses research studies study programs clinical